Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating cancer and application of pharmaceutical composition

A composition and drug technology, applied in the field of pharmaceutical compositions for the treatment of cancer, can solve problems such as liver damage and bone marrow suppression, and achieve the effect of reducing toxicity, reducing damage, making and administering conveniently and quickly

Inactive Publication Date: 2018-11-06
SUZHOU UNIV
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, this chemotherapy drug can cause considerable side effects on the body tissue, such as bone marrow suppression, liver damage, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for treating cancer and application of pharmaceutical composition
  • Pharmaceutical composition for treating cancer and application of pharmaceutical composition
  • Pharmaceutical composition for treating cancer and application of pharmaceutical composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0063] Example 1, the inhibitory effect of methotrexate and JQ-1 inhibitors on the growth of human pancreatic cancer cell Panc1 cells

[0064] Cell proliferation detected by CCK-8 method: Panc1 cells were inoculated with 10% fetal bovine serum, 1×10 5 U / L penicillin and 100g / L streptomycin in DMEM medium, 5% CO 2 Incubator at 37°C. Panc1 cells in the logarithmic growth phase were divided into 3 × 10 3 and 5×10 3 seeded in 96-well plates. After culturing for 24 hours, 0, 10, 20, 40, 100, 200, 400 nM of MTX and 0, 125, 250 nM of JQ-1 inhibitor were added. Four replicate wells were set up in each group, and a negative control was set up at the same time. placed in 5% CO 2 Incubate at 37°C for 24h and 48h. Add 10 μL of CCK-8 solution to each well, continue to incubate in the cell culture incubator for 1 hour, and measure the absorbance at 450 nm. Calculate the inhibition rate according to the following formula:

[0065] Survival rate (%)=[(A450, Sample-A450, Blank) / (A450,...

Embodiment 2

[0070] Example 2, methotrexate and JQ-1 inhibitors induce cell death and autophagy in human pancreatic cancer cells Panc1

[0071] In this example, the concentration of MTX used is 100nM / L, and the relative molecular mass is 454.44g / mol; the concentration of JQ-1 inhibitor is 200nM / L, and the relative molecular mass is 456.99g / mol.

[0072] How to use MTX: (1) Dissolve MTX in DMSO to make 10mM stock solution; (2) Dilute to 100nmol / L with cell culture medium and add to cell culture dish.

[0073]

[0074] JQ-1 inhibitor usage method: (1) JQ-1 inhibitor is dissolved in DMSO, and prepared as a 10mM stock solution; (2) used for cell culture and diluted to 200nmol / L, and added to a cell culture dish.

[0075]

[0076] Combined use of MTX+JQ-1 inhibitor: Take appropriate amount of stock solution of JQ-1 and MTX and dilute to a specific concentration with culture medium (JQ-1 inhibitor 200nM, MTX 100nM).

[0077] AnnexinV-PE / 7-AAD double staining combined with flow cytometry t...

Embodiment 3

[0087] Example 3, MTX and JQ-1 inhibitors jointly affect the folic acid, purine and pyrimidine synthesis pathways of pancreatic cancer cells

[0088] The gene chip clarified the cellular processes affected by JQ-1 inhibitors: treated Panc1 cells with JQ-1 inhibitors and DMSO (control), extracted RNA for gene chip analysis; used bioinformatics methods to find differentially expressed genes and analyzed them Pathway analysis. See Figure 14 and Figure 15 , as can be seen from the figure, the bioinformatics method screened out the 100 most significantly changed differential genes after JQ-1 inhibitor treatment, GO and KEGG pathway analysis showed that the synthesis of purine and pyrimidine was significantly affected after JQ-1 inhibitor treatment .

[0089] Real-time fluorescent quantitative PCR detection of key gene changes in folic acid, purine and pyrimidine synthesis pathways: Panc1 cells were treated with MTX and JQ-1 inhibitors, RNA was extracted, and real-time fluoresc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a pharmaceutical composition for treating the cancer and an application of the pharmaceutical composition. The pharmaceutical composition comprises methotrexate as an active ingredient and a BRD4 protein inhibitor, and the mass ratio of the methotrexate to the BRD4 protein inhibitor ranges from 10:1 to 1:8. The pharmaceutical composition obviously improves the chemotherapeutic effect of the methotrexate, the similar chemotherapeutic effect is achieved by using the methotrexate at the relatively low concentration, therefore, the toxicity on a nude mouth is obviously reduced, and the injury of the pharmaceutical composition on the organism is reduced, so that the pharmaceutical composition is applied to preparation of anti-tumor drugs.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating cancer and its application, belonging to the technical field of medicines. Background technique [0002] Pancreatic cancer is a digestive system tumor with a high degree of malignancy and a very poor prognosis. Pancreatic cancer is the fourth leading cause of cancer-related death in the United States, and despite advances in treatment, the 5-year survival rate remains <8% (CA Cancer J Clin. 2018;68(1):7–30.). In 2016, the American Cancer Society pointed out that the median survival period of pancreatic cancer without distant metastasis is 6-10 months, and the median survival period of distant metastasis is 3-6 months (J Clin Oncol.2016; 34(22): 2654.). Research by Luo et al. showed that the 5-year survival rate of pancreatic cancer patients in Shanghai was 4.1% from 2004 to 2009, and the median survival period was 3.9 months (PLoS One.2014; 9(1):301–8.). The clinical practice guid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/519A61K31/551A61P35/00
CPCA61K31/519A61K31/551A61P35/00A61K2300/00
Inventor 曹建平俞辰逍朱巍岳凌焦旸薛姣
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com